Survivin mediates self-protection through ROS/cdc25c/CDK1 signaling pathway during tumor cell apoptosis induced by high fluence low-power laser irradiation

Cancer Letters

Volumn 297, Issue 2, 2010, Pages 207-219

  Chu, Jiru ^a   Wu, Shengnan ^a   Xing, Da ^a  

^a SOUTH CHINA NORMAL UNIVERSITY   (China)

Author keywords

Apoptosis; High fluence low power laser irradiation (HF LPLI); Self protection; Survivin

Indexed keywords

CASPASE 9; CYCLIN DEPENDENT KINASE 1; CYTOCHROME C; PROTEIN BAX; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE C; SURVIVIN; UNCLASSIFIED DRUG; BAX PROTEIN, HUMAN; BIRC5 PROTEIN, HUMAN; CASPASE; CASPASE INHIBITOR; CDC25C PROTEIN, HUMAN; INHIBITOR OF APOPTOSIS PROTEIN; MICROTUBULE ASSOCIATED PROTEIN; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DEPOLARIZATION; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME RELEASE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LASER; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION; ANTAGONISTS AND INHIBITORS; CELL SURVIVAL; GENETIC TRANSFECTION; LOW LEVEL LASER THERAPY; LUNG NEOPLASMS; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PROCEDURES; RADIATION RESPONSE; TUMOR CELL LINE;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASES; CDC2 PROTEIN KINASE; CDC25 PHOSPHATASES; CELL LINE, TUMOR; CELL SURVIVAL; CYTOCHROME C GROUP; HUMANS; LASER THERAPY, LOW-LEVEL; LUNG NEOPLASMS; MICROTUBULE-ASSOCIATED PROTEINS; PHOSPHORYLATION; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TRANSFECTION; UP-REGULATION; CASPASE INHIBITORS; INHIBITOR OF APOPTOSIS PROTEINS;

EID: 77956399828     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2010.05.013     Document Type: Article

References (36)

1. Karu T. Photobiology of low-power laser effect. Health Phys. 1989, 56:691-704.
2. Lubart R., Eichler M., Lavi R., Friedman H., Shainberg A. Low-energy laser irradiation promotes cellular redox activity. Photomed. Laser Surg. 2005, 23:3-9.
3. Nadav B.D., Gavriella S., Andrey I., Anton W., Uri O., Orna H. Low-energy laser irradiation affects satellite cell proliferation and differentiation in vitro. Biochem. Biophys. Acta 1999, 1448:372-380.
4. Wu S.N., Xing D., Wang F., Chen T.S., Chen W. Mechanistic study of apoptosis induced by high fluence low-power laser irradiation using fluorescence imaging techniques. J. Biomed. Opt. 2007, 12:064015.
5. Wu S.N., Xing D., Gao X.J., Chen W. High fluence low-power laser irradiation induces mitochondrial permeability transition mediated by reactive oxygen species. J. Cell Physiol. 2008, 218:603-611.
6. Gao X.J., Chen T.S., Xing D., Wang F., Pei Y.H., Wei X.B. Single cell analysis of PKC activation during proliferation and apoptosis induced by laser irradiation. J. Cell Physiol. 2006, 206:41-48.
7. Zhang L.L., Xing D., Gao X.J., Wu S.N. Low-power laser irradiation promotes cell proliferation by activating PI3K/Akt pathway. J. Cell Physiol. 2009, 219:553-562.
8. Zhang J.T., Xing D., Gao X.J. Low-power laser irradiation activates Src tyrosine kinase through reactive oxygen species-mediated signaling pathway. J. Cell Physiol. 2008, 217:518-528.
9. Gao X.J., Xing D., Liu L., Tang Y.H. H-Ras and PI3K are required for the formation of circular dorsal ruffles induced by low-power laser irradiation. J. Cell Physiol. 2009, 219:535-543.
10. Karu T. Effects of visible radiation on cultured cells. Photochem. Photobiol. 1990, 52:1089-1098.
11. O'Kane S., Shields T.D., Gilmore W.S., Allen J. Low intensity laser irradiation inhibits tritiated thymidine incorporation in the hemopoietic cell lines HL-60 and U937. Lasers Surg. Med. 1994, 14:34-39.
12. Wang F., Chen T.S., Xing D., Wang J.J., Wu Y.X. Measuring dynamics of caspase-3 activity in living cells using FRET technique during apoptosis induced by high fluence low-power laser irradiation. Lasers Surg. Med. 2005, 36:2-7.
13. Deveraux Q.L., Reed J.C. IAP family proteins: suppressors of apoptosis. Genes Dev. 1999, 13:239-252.
14. Altieri D.C. The molecular basis and potential role of survivin in cancer diagnosis and therapy. Trends Mol. Med. 2001, 7:542-547.
15. Altieri D.C. Survivin, cancer networks and pathway-directed drug discovery. Nat. Rev. Cancer 2008, 8:61-70.
16. O'Connor D.S., Grossman D., Plescia J. Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin. Proc. Natl. Acad. Sci. USA 2000, 97:13103-13107.
17. Hoffman W.H., Biade S., Zilfou J.T., Chen J., Murphy M. Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. J. Biol. Chem. 2002, 277:3247-3257.
18. Grossman D., Kim P.J., Schechner J.S., Altieri D.C. Inhibition of melanoma tumor growth in vivo by survivin targeting. Proc. Natl. Acad. Sci. USA 2001, 98:635-640.
19. Mesri M., Wall N.R., Li J., Kim R.W., Altieri D.C. Cancer gene therapy using a survivin mutant adenovirus. J. Clin. Invest. 2001, 108:981-990.
20. Yamaura M., Mitsushita J., Furuta S. NADPH oxidase 4 contributes to transformation phenotype of melanoma cells by regulating G2-M cell cycle progression. Cancer Res. 2009, 69:2647-2654.
21. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
22. Evan G.I., Vousden K.H. Proliferation, cell cycle and apoptosis in cancer. Nature (London) 2001, 411:342-348.
23. Kanwar J.R., Shen W.P., Kanwar R.K., Berg R.W., Krissansen G.W. Effects of survivin antagonists on growth of established tumors and B7-1 immunogene therapy. J. Natl. Cancer Inst. (Bethesda) 2001, 93:1541-1552.
24. Wall N.R., O'Connor D.S., Plescia J. Suppression of survivin phosphorylation on Thr34 by flavopiridol enhances tumor cell apoptosis. Cancer Res. 2003, 63:230-235.
25. Ferrario A., Rucker N., Wong S. Survivin, a member of the inhibitor of apoptosis family, is induced by photodynamic therapy and is a target for improving treatment response. Cancer Res. 2007, 67:4989-4995.
26. You R.I., Chen M.C., Wang H.W., Hsieh S.L. Inhibition of lymphotoxin-β receptor-mediated cell death by survivin-ΔEx3. Cancer Res. 2006, 66:3051-3061.
27. Ogura A., Watanabe Y., Inanami O. Radiation-induced apoptosis of tumor cells is facilitated by inhibition of the interaction between Survivin and Smac/DIABLO. Cancer Lett. 2008, 259:71-81.
28. Obexer P., Hagenbuchner J., Unterkircher T. Repression of BIRC5/Survivin by FOXO3/ FKHRL1 sensitizes human neuroblastoma cells to DNA damage-induced apoptosis. Mol. Biol. Cell 2009, 20:2041-2048.
29. Wu Y., Xing D., Chen W.R., Wang X. Bid is not required for Bax translocation during UV-induced apoptosis. Cell Signal. 2007, 19:2468-2478.
30. Boldt S., Weidle U.H., Kolch W. The role of MAPK pathways in the action of chemotherapeutic drugs. Carcinogenesis 2002, 23:1831-1838.
31. Altieri D.C. Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene 2003, 22:8581-8589.
32. Altieri D.C. Validating survivin as a cancer therapeutic target. Nat. Rev. Cancer 2003, 3:46-54.
33. Dohi T., Okada K., Xia F., Wilford C.E. An IAP-IAP complex inhibits apoptosis. J. Biol. Chem. 2004, 279:34087-34090.
34. Dohi T., Xia F., Altieri D.C. Compartmentalized phosphorylation of IAP by protein kinase A regulates cytoprotection. Mol. Cell 2007, 27:17-28.
35. Gomer C.J., Ferrario A., Luna M., Rucker N., Wong S. Photodynamic therapy: combined modality approaches targeting the tumor microenvironment. Lasers Surg. Med. 2006, 38:516-521.
36. Monzo M., Rosell R., Felip E., Astudillo J., Sanchez J.J. A novel anti-apoptosis gene: re-expression of survivin messenger RNA as a prognostic marker in non-small cell lung cancers. J. Clin. Oncol. 1999, 17:2100-2104.